lobbying_activities: 2511582

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2511582	477d1e44-3018-4e5d-9837-4a3485169a6c	Q3	SAFEWAY INC.	300173	SAFEWAY	2020	third_quarter	PHA	CMS Medicaid Part D Final Rule, provisions related to DIR Fees H.R. 1034, S. 640 - Phair Pricing Act, all provisions H.R. 1614, S. 724 - John S. McCain Opioid Addiction Prevention Act, all provisions Issues related to pharmacist provider status S 2543 - Prescription Drug Pricing Reduction Act of 2019 - provisions related to Medicare Part D drug pricing. HHS Proposed Rule - Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees	HOUSE OF REPRESENTATIVES,SENATE		90000	0	0	2020-10-16T15:09:43.717000-04:00